Anatara Lifesciences Ltd (ANR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -1.45 Million AUD | 28.27% |
| 2023 | -2.02 Million AUD | 20.1% |
| 2022 | -2.53 Million AUD | -26.88% |
| 2021 | -1.99 Million AUD | 40.68% |
| 2020 | -3.36 Million AUD | -17.31% |
| 2019 | -2.86 Million AUD | 19.63% |
| 2018 | -3.56 Million AUD | -109.33% |
| 2017 | -1.7 Million AUD | -135.52% |
| 2016 | -723.93 Thousand AUD | 59.67% |
| 2015 | -1.79 Million AUD | -108.06% |
| 2014 | -862.85 Thousand AUD | -365.42% |
| 2013 | -185.39 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -1.45 Million AUD | 28.27% |
| 2024 Q4 | -772.05 Thousand AUD | 0.0% |
| 2024 Q2 | -679.18 Thousand AUD | 0.0% |
| 2023 FY | -2.02 Million AUD | 20.1% |
| 2023 Q4 | -1.06 Million AUD | 0.0% |
| 2023 Q2 | -955.71 Thousand AUD | 0.0% |
| 2022 Q2 | -1.19 Million AUD | 0.0% |
| 2022 FY | -2.53 Million AUD | -26.88% |
| 2022 Q4 | -1.33 Million AUD | 0.0% |
| 2021 Q4 | -966.44 Thousand AUD | 0.0% |
| 2021 Q2 | -1.02 Million AUD | 0.0% |
| 2021 FY | -1.99 Million AUD | 40.68% |
| 2020 Q2 | -1.8 Million AUD | 0.0% |
| 2020 FY | -3.36 Million AUD | -17.31% |
| 2020 Q4 | -1.56 Million AUD | 0.0% |
| 2019 FY | -2.86 Million AUD | 19.63% |
| 2019 Q4 | -847.23 Thousand AUD | 0.0% |
| 2019 Q2 | -2.02 Million AUD | 0.0% |
| 2018 FY | -3.56 Million AUD | -109.33% |
| 2018 Q4 | -1.85 Million AUD | 0.0% |
| 2018 Q2 | -1.71 Million AUD | 0.0% |
| 2017 Q2 | -402.28 Thousand AUD | 0.0% |
| 2017 FY | -1.7 Million AUD | -135.52% |
| 2017 Q4 | -1.3 Million AUD | 0.0% |
| 2016 Q2 | -1.17 Million AUD | 0.0% |
| 2016 FY | -723.93 Thousand AUD | 59.67% |
| 2016 Q4 | 455.24 Thousand AUD | 0.0% |
| 2015 Q2 | -775.98 Thousand AUD | 0.0% |
| 2015 FY | -1.79 Million AUD | -108.06% |
| 2015 Q4 | -1.01 Million AUD | 0.0% |
| 2014 Q3 | - AUD | 100.0% |
| 2014 Q2 | -123.07 Thousand AUD | 0.0% |
| 2014 FY | -862.85 Thousand AUD | -365.42% |
| 2014 Q4 | -739.78 Thousand AUD | 0.0% |
| 2013 FY | -185.39 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 73.032% |
| Acrux Limited | -5.8 Million AUD | 74.979% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 89.537% |
| BTC Health Limited | 1.05 Million AUD | 237.521% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 88.418% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 96.571% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 104.072% |
| Biome Australia Limited | -1.67 Million AUD | 13.11% |
| Hexima Limited | -933.87 Thousand AUD | -55.4% |
| Immutep Limited | -39.89 Million AUD | 96.362% |
| Memphasys Limited | -4.44 Million AUD | 67.329% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 100.924% |
| Noxopharm Limited | -3.57 Million AUD | 59.441% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 82.384% |
| Race Oncology Limited | -13.81 Million AUD | 89.498% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 96.973% |
| Starpharma Holdings Limited | -8.16 Million AUD | 82.226% |
| Tissue Repair Ltd | -4.13 Million AUD | 64.93% |
| Biotron Limited | -3.43 Million AUD | 57.77% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 92.411% |
| CSL Limited | 2.64 Billion AUD | 100.055% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 120.838% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 39.762% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 96.031% |
| Patrys Limited | -3.53 Million AUD | 58.995% |
| Orthocell Limited | -7.18 Million AUD | 79.79% |
| Imugene Limited | -149.68 Million AUD | 99.03% |
| PYC Therapeutics Limited | -37.72 Million AUD | 96.153% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 77.24% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 85.107% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 83.407% |
| Nanollose Limited | -1.15 Million AUD | -25.48% |
| Invex Therapeutics Ltd | -1.64 Million AUD | 11.607% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 547.624% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 67.775% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 49.334% |
| Nyrada Inc. | -1.38 Million AUD | -4.69% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 127.85% |
| Dimerix Limited | -17.07 Million AUD | 91.501% |
| PharmAust Limited | -9.03 Million AUD | 83.933% |
| AnteoTech Limited | -8.88 Million AUD | 83.658% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 97.526% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 91.783% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 57.771% |
| Actinogen Medical Limited | -13.04 Million AUD | 88.874% |
| Immuron Limited | -6.93 Million AUD | 79.08% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 73.515% |